spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  ER-SPEC 

 HSMN NewsFeed - 3 Dec 2025
Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
Devices Orthopaedic
 HSMN NewsFeed - 15 Jan 2025
New Drug Application Initiated with U.S. FDA for TAR-200, the First and Only Intravesical Drug Releasing System for Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 24 Oct 2024
Accent Therapeutics Announces FDA Clearance of IND Application for ATX-559, a First-In-Class Oral DHX9 Inhibitor
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Apr 2022
New BD Reagents Enable Researchers to Break Through Resolution Boundaries in Flow Cytometry
Diagnostics Product Launch
 HSMN NewsFeed - 5 Jan 2022
Meridian Bioscience Receives FDA Clearance for the Curian(R) Campy Assay
Diagnostics FDA
 HSMN NewsFeed - 14 Jul 2021
First in Human Procedure with Vessi Medical's Cryotherapy System for Bladder Cancer
Devices Urology Oncology
 HSMN NewsFeed - 11 Jan 2021
Marizyme Announces the Use of DuraGraft(R) as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf
Devices Cardiology
 HSMN NewsFeed - 31 Aug 2020
Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment
Devices Urology Oncology Venture Capital
 HSMN NewsFeed - 26 Mar 2020
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jan 2020
SutroVax Announces Executive Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2019
BioGX Receives CE-IVD Mark For Enhanced Flu Assay
Diagnostics Regulatory
 HSMN NewsFeed - 28 Feb 2019
Daiichi Sankyo Europe and Esperion Announce Validation of the Marketing Authorisation Application (MAA) for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Fixed Dose Combination Tablet
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 14 Jan 2019
SutroVax Announces Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2018
BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)
Diagnostics Regulatory Product Launch
 HSMN NewsFeed - 12 Oct 2018
Lilly and Metastatic Breast Cancer Advocates Launch Thriver Movement to Elevate Understanding of the Daily Impact of the Disease, Encourage Public to do More for MBC
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 5 Jul 2018
5-Year Outcomes Following A HIFU Focal Therapy Study Demonstrate Impressive Disease Control And Low Side Effect Profile For Prostate Cancer Patients In The U.K.
Devices Oncology
 HSMN NewsFeed - 27 Jun 2018
Adicet Bio appoints Stewart Abbot, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jun 2018
SutroVax Announces $85M Series C Financing led by TPG Growth
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 24 May 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
Diagnostics Product Launch
 HSMN NewsFeed - 30 Apr 2018
Adicet Bio appoints Elizabeth "EJ" Read, M.D. as Chief Technology Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jan 2018
TECHLAB Receives FDA 510(k) Clearance To Market CAMPYLOBACTER QUIK CHEK(TM) and CAMPYLOBACTER CHEK(TM) Tests
Diagnostics Gastroenterology Product Launch
 HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2017
New Data Show TomoTherapy(R) System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers
Devices Oncology
 HSMN NewsFeed - 19 Jul 2017
Dr. Moncef Slaoui, former GlaxoSmithKline Chairman of Vaccines, Appointed to SutroVax Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2017
Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President & CEO to Commercialize Proprietary Theralink(R) Tumor Biomarker Platform
Diagnostics Oncology Personnel
 HSMN NewsFeed - 7 Jun 2017
Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 May 2017
New Data Reinforce Benefits of TomoTherapy(R) Platform for Mainstream Radiation Therapy Treatment Indications
Devices Oncology
 HSMN NewsFeed - 4 May 2017
OBP Medical Launches Expanded Portfolio of Single-Use Lighted Specula at ACOG 2017
Devices Product Launch
 HSMN NewsFeed - 28 Mar 2017
Nuvo Pharmaceuticals(TM) Enters into Pennsaid(R) 2% License Agreement with Sayre Therapeutics PVT Ltd. for India, Sri Lanka, Bangladesh and Nepal
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Mar 2017
SutroVax Announces Closing of $64M via Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 1 Mar 2017
Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing Treatment for MPS II
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Diagnostics Personnel
 HSMN NewsFeed - 9 Dec 2016
Genomic Health Announces Results from Multiple Oncotype DX(R) Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 20 Jun 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2016
Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs
Biopharmaceuticals Oncology Venture Capital Licensing
 HSMN NewsFeed - 8 Feb 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2015
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 26 Oct 2015
Hitachi Medical Systems Europe to Present a New Era in Endoscopic Ultrasound (EUS) With its New Ultrasound Platform ARIETTA Endoscopic
Devices Product Launch
 HSMN NewsFeed - 1 May 2014
Myriad to Launch EndoPredict(R) in Canada
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 3 Mar 2014
Myriad Publishes Clinical Utility Study for Prolaris(R)
Diagnostics Urology
 HSMN NewsFeed - 29 Jan 2014
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 4 Dec 2013
Myriad's Prolaris(R) Test Guides Treatment Decisions for Men with Prostate Cancer
Diagnostics Urology Oncology
 HSMN NewsFeed - 28 Oct 2013
Myriad myPlan(TM) Lung Cancer Test Meets Primary Endpoint in Validation Study
Diagnostics Oncology
 HSMN NewsFeed - 22 Feb 2013
EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer
Devices Urology Oncology
 HSMN NewsFeed - 30 Oct 2012
BioNTech AG Appoints Sean Marett as COO (Chief Operating Officer)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2012
CardioDx’s Corus CAD Gene Expression Test Performs Equally Well in Both Women and Men for the Assessment of Obstructive Coronary Artery Disease, Study Shows
Diagnostics Cardiology
 HSMN NewsFeed - 26 Jun 2012
Caris Life Sciences Launches Caris Target Now(TM) Select for NSCLC, Melanoma, and Cancers of the Breast, Colon, and Ovary
Diagnostics Oncology
 HSMN NewsFeed - 3 Aug 2010
GenSpera Acquires Rights to Cancer Imaging Technology to Create a New Generation of Medical Imaging Tools for Oncologists
Devices Radiology Oncology Acquisitions
 HSMN NewsFeed - 7 Jun 2010
Immunomedics Reports Updated Results of Targeted Therapy for Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jan 2010
Ligand Completes Acquisition of Metabasis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Jan 2010
MabCure Launches Clinical Trial to Diagnose Ovarian Cancer
Diagnostics Oncology
 HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Jun 2009
ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2009
Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Mar 2009
Boston Scientific Announces Schedule For ACC 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2008
Pathwork Diagnostics Announces Key Additions to Management Team
Diagnostics Personnel
 HSMN NewsFeed - 12 Sep 2008
Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
Diagnostics Personnel
 HSMN NewsFeed - 3 Sep 2008
Exosome Diagnostics Announces Additions to Management Team
Diagnostics Oncology Personnel
 HSMN NewsFeed - 31 Jul 2008
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
Diagnostics Oncology FDA
 HSMN NewsFeed - 14 Jul 2008
Radiofrequency Ablation Yields High Proportions of Sustained Complete Responses in Patients with Lung Cancer
Devices Oncology
 HSMN NewsFeed - 8 Jul 2008
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 12 May 2008
HepaLife's Bioartificial Liver Exceeds Expectations in New Tests Conducted over Prolonged Periods of Time
Devices
 HSMN NewsFeed - 20 Feb 2008
Cook Pharmica Names Fred Larimore, Ph.D., Vice President of Scientific Affairs, CSO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2007
Cook Pharmica Signs Agreement with Inspiration Biopharmaceuticals for the Transfer of its Clinical Manufacturing Process for Lead Hemophilia Compound
Biopharmaceuticals
 HSMN NewsFeed - 25 Oct 2007
Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Oct 2007
New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer
Devices Oncology
 HSMN NewsFeed - 26 Sep 2007
HepaLife(TM) Releases Positive New Research Results for First-of-Its-Kind Bioartificial Liver
Devices Regenerative Medicine
 HSMN NewsFeed - 24 Sep 2007
Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Aug 2007
HepaLife(TM) Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010
Devices
 HSMN NewsFeed - 6 Aug 2007
TomoTherapy Co-Founder to Receive Health Breakthrough Award from Ladies' Home Journal
Devices Oncology
 HSMN NewsFeed - 30 Jul 2007
The New Cook Medical Resonance(R) Metallic Ureteral Stent Improves Patient Quality of Life During Cancer Treatment
Devices Interventional Urology Oncology
 HSMN NewsFeed - 4 Jun 2007
Pre-menopausal Estrogen Levels Linked to Higher Death Rate Among Women Receiving Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2007
Outcomes Data Continue to Demonstrate Value of Cytogen's PROSTASCINT(R) to Predict Prognosis in Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Apr 2007
Baxter Introduces HYLENEX for Use in Ophthalmic Surgery
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Apr 2007
GANYMED Raises Euro 33.7 Million in Series C Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 14 Apr 2007
KCI Investigators Present Breast Cancer Findings
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Mar 2007
Wright Medical Group, Inc. Introduces New Stature-Specific Knee Replacement
Devices Orthopaedic
 HSMN NewsFeed - 13 Mar 2007
Philips Introduces Transport Monitor and on-Screen Protocol Compliance Application
Devices Monitoring
 HSMN NewsFeed - 22 Dec 2006
SciClone and Sigma-Tau Announce Positive Interim Survival Data From Large Phase 2 Malignant Melanoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Sep 2006
Tibotec Therapeutics Announces Initiation of the Largest U.S. Clinical Study Examining HIV Treatment in Treatment-Experienced Adult Women
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 6 Jul 2006
Pathwork Diagnostics Formed From Venture-Backed Acquisition
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 5 Jul 2006
Geron Presents New Data That Document Progress in Development of Therapeutic Products from Human Embryonic Stem Cells
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 1 Jun 2006
Cell Therapeutics, Inc. (CTI) and FDA Agree on NDA Filing Strategy for XYOTAX(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 May 2006
Matritech's NMP22(R) BladderChek(R) Test Could Save Lives and Reduce Expense in Screening High Risk Populations for Bladder Cancer
Diagnostics Oncology
 HSMN NewsFeed - 10 May 2006
The Shape of Things to Come: Gender Solutions(TM) High-Flex Knee is the First Knee Replacement Shaped to Fit a Woman's Anatomy
Devices Orthopaedic FDA
Return to NewsFeed  

 Additional items found! 15

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 15 additional stories matching:
ER-SPEC
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!